Anti-CD6 ligand antibodies
US5998172A · kind A · utility
8Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 18, 1996 |
| Grant date | Dec 7, 1999 |
| Priority date | — |
| Expiry date | Jul 18, 2016 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70503
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to CD6 and, in particular, to a CD6 ligand present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cell types. The invention further relates to methods of inhibiting the interaction of CD6 and the CD6 ligand, and to methods of screening compounds for their ability to inhibit that interaction. The invention also relates to antibodies, and binding fragments thereof, specific for CD6 ligand.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.